ClinicalTrials.Veeva

Menu
G

Geisinger Clinic | Geisinger Danville - Anesthesiology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
Bevacizumab
Trastuzumab
Setmelanotide
Otamixaban
JZP-258
Nicardipine
XRP0673
Paclitaxel
Nitroglycerin

Parent organization

This site is a part of Geisinger Clinic

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 48 total trials

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

The SUMMIT MAX study is a prospective, randomized, controlled, interventional clinical trial to evaluate the safety and effectiveness of the Route 92...

Active, not recruiting
Acute Ischemic Stroke
Device: Route 92 Medical Reperfusion System
Locations recently updated

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Rest...

Enrolling
Dilated Cardiomyopathy
Heart Failure With Reduced Ejection Fraction (HFrEF)
Device: AccuCinch Ventricular Restoration System
Drug: Guideline-Directed Medical Therapy

A 2-stage (open-label run-in, followed by randomized, double-blind, placebo-controlled withdrawal) trial of setmelanotide in patients with obesity an...

Active, not recruiting
Genetic Obesity
Drug: Placebo
Drug: Setmelanotide

The protocol describes a randomized, double-blind, placebo-controlled trial with independent sub-studies of setmelanotide in patients with obesity an...

Enrolling
Genetic Obesity
Obesity
Drug: Placebo
Drug: Setmelanotide

The primary objective of this trial is to compare the safety and efficacy of the SINOMED BuMA Supreme biodegradable coronary stent in patients with u...

Active, not recruiting
Coronary Artery Disease
Device: Xience or Promus DES
Device: BuMA Supreme DES

This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non al...

Active, not recruiting
Non-alcoholic Steatohepatitis
Drug: Placebo (NNC0194-0499)
Drug: NNC0174 0833 placebo

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...

Active, not recruiting
Non-alcoholic Steatohepatitis
Drug: Placebo
Drug: Semaglutide

Trial sponsors

Geisinger Health logo
Boston Scientific logo
N
Novo Nordisk logo
Rhythm Pharmaceuticals logo
N
A
A
B
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems